Press release
Fighting Chemotherapy Side Effects: Myelosuppression Treatment Market 2024
As per the report, the chemotherapy-induced myelosuppression treatment market size has grown steadily in recent years. It will grow from $7.65 billion in 2023 to $7.97 billion in 2024 at a compound annual growth rate (CAGR) of 4.3%. The chemotherapy-induced myelosuppression treatment market size is expected to see steady growth in the next few years. It will grow to $9.60 billion in 2028 at a compound annual growth rate (CAGR) of 4.7%.
Download Free Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=16372&type=smp
Impact Of Rising Cancer Prevalence On The Chemotherapy-Induced Myelosuppression Treatment Market
The rising prevalence of cancer is expected to propel the growth of the chemotherapy-induced myelosuppression treatment market going forward. Cancer is the unregulated growth and spread of abnormal cells, often leading to the invasion of surrounding tissues and organs, disrupting their normal function, and potentially threatening the overall health and well-being of the individual. The prevalence of cancer is due to exposure to pollution, radiation, certain chemicals, and carcinogens. Chemotherapy-induced myelosuppression treatment is essential in cancer care for managing the hematological side effects caused by chemotherapy, which is a standard treatment modality for various types of cancer. For instance, in May 2024, according to the American Society of Clinical Oncology, a US-based professional organization, an estimated 20 million new cancer cases were found in 2022, and expected to reach 35 million new cases globally by 2050. Therefore, the rising prevalence of cancer is driving the chemotherapy-induced myelosuppression treatment market.
Innovative Developments In Myeloprotection Therapy For Chemotherapy-Induced Myelosuppression Treatment
Major companies operating in the chemotherapy-induced myelosuppression treatment market focus on developing innovative products, such as myeloprotection therapy, to enhance treatment efficacy and patient experience. Myeloprotection therapy refers to medical interventions to protect the bone marrow and hematopoietic stem cells from damage caused by specific treatments, particularly chemotherapy and radiation therapy. For instance, in February 2021, G1 Therapeutics Inc., a US-based biopharmaceutical company, launched COSELA (trilaciclib) for injection to lessen the frequency of myelosuppression caused by chemotherapy in adult patients, which was approved by the Food and Drug Administration (FDA), a US-based federal agency. This innovative approach alleviates common chemotherapy side effects like neutropenia, anemia, and thrombocytopenia, often leading to dose reductions or treatment delays. Cosela integrates smoothly into existing chemotherapy regimens across different cancer types, enhancing patient tolerance and supporting continuous therapy delivery, potentially improving overall treatment outcomes and quality of life.
The chemotherapy-induced myelosuppression treatment market covered in this report is segmented -
1) By Indication: Anemia, Neutropenia, Thrombocytopenia
2) By Drug Class: Growth Factors, Erythropoietin Stimulating Agents, Thrombopoietic Agents, Iron Supplements, Other Drug Classes
3) By Route Of Administration: Oral, Injectable
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
Buy Now & Get Exclusive Discount on this Report, Checkout link @
https://www.thebusinessresearchcompany.com/Discount?id=16372&type=discount
Major companies operating in the chemotherapy-induced myelosuppression treatment market are Merck & Co. Inc., Bayer AG, Sanofi SA, Abbott Laboratories, Novartis AG, Glaxo Smith Kline plc, Amgen Inc., Viatris Inc., Biogen SA, Bausch Health Companies Inc., Cipla Inc., Hikma Pharmaceuticals PLC,Lupin Ltd, Seagen Inc, Mission Pharmacal Company, G1 Therapeutics Inc., Spectrum Pharmaceuticals Inc., Partner Therapeutics Inc., Myelo Therapeutics GmbH, Evive Biotech Inc.
Contents of the report:
1. Executive Summary
2. Chemotherapy-Induced Myelosuppression Treatment Market Report Structure
3. Chemotherapy-Induced Myelosuppression Treatment Market Trends And Strategies
4. Chemotherapy-Induced Myelosuppression Treatment Market - Macro Economic Scenario
5. Chemotherapy-Induced Myelosuppression Treatment Market Size And Growth
…..
27. Chemotherapy-Induced Myelosuppression Treatment Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Explore the report store to make a direct purchase of the report @
https://www.thebusinessresearchcompany.com/report/chemotherapy-induced-myelosuppression-treatment-global-market-report
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Fighting Chemotherapy Side Effects: Myelosuppression Treatment Market 2024 here
News-ID: 3626684 • Views: …
More Releases from the business research company
Future Perspective: Key Trends Shaping the Signal Conditioning Modules Market Up …
The signal conditioning modules market is on track for significant expansion over the coming years, driven by advancements in various industrial and technological sectors. This growth reflects the increasing need for precise signal management and integration with emerging smart technologies that are shaping modern automation and data acquisition systems.
Projected Growth Trajectory of the Signal Conditioning Modules Market
The signal conditioning modules market is anticipated to reach a valuation of $1.77…
Emerging Sub-Segments Transforming the Set-Top Box Market Dynamics
The set-top box market is on the cusp of significant expansion as technology and consumer preferences continue to evolve rapidly. With the increasing demand for advanced streaming and broadcasting solutions, this sector is poised for substantial growth over the coming years. Let's explore the market's projected size, leading companies, key trends, and the segments driving this development.
Projected Market Growth of the Set-Top Box Industry by 2030
The set-top box market…
Market Trend Analysis: The Impact of Recent Innovations on the Semiconductor Waf …
The semiconductor wafer sector is gearing up for significant expansion as technological advancements and diverse industry demands drive its growth. With applications spanning from electric vehicles to telecommunications, this market is positioned for steady development in the years ahead. Let's explore the anticipated market size, key players, emerging trends, and segmentation details shaping the future of this vital industry.
Projected Market Size and Growth Trajectory of the Semiconductor Wafer Market
Forecasts…
Leading Companies Reinforce Their Presence in the Semiconductor Manufacturing Eq …
The semiconductor manufacturing equipment market is poised for significant expansion as the demand for high-performance chips and advanced packaging technologies continues to grow. This evolving sector is driven by technological progress and increased investments, setting the stage for substantial developments through 2030.
Projected Semiconductor Manufacturing Equipment Market Size and Growth
The semiconductor manufacturing equipment market is forecasted to reach a value of $196.07 billion by 2030, growing at a compound annual…
More Releases for Myelo
Chemotherapy Induced Neutropenia Market Predicted to See Upsurge Through 2032, H …
DelveInsight's "Chemotherapy Induced Neutropenia Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Chemotherapy Induced Neutropenia, historical and forecasted epidemiology as well as the Chemotherapy Induced Neutropenia market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Chemotherapy Induced Neutropenia market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Chemotherapy Induced Neutropenia…
Chemotherapy Induced Neutropenia Market Forecasted to Surge in Coming Years, 202 …
DelveInsight's "Chemotherapy Induced Neutropenia Market Insights, Epidemiology, and Market Forecast-2034″ report offers an in-depth understanding of the Chemotherapy Induced Neutropenia, historical and forecasted epidemiology as well as the Chemotherapy Induced Neutropenia market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Chemotherapy Induced Neutropenia market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Chemotherapy Induced Neutropenia…
Chemotherapy Induced Neutropenia Market is Expected to Expand at a Healthy Growt …
DelveInsight's "Chemotherapy Induced Neutropenia Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Chemotherapy Induced Neutropenia, historical and forecasted epidemiology as well as the Chemotherapy Induced Neutropenia market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Chemotherapy Induced Neutropenia market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Chemotherapy Induced Neutropenia…
Chemotherapy Induced Neutropenia Market Report 2032: Epidemiology Data, Pipeline …
DelveInsight's "Chemotherapy Induced Neutropenia Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Chemotherapy Induced Neutropenia, historical and forecasted epidemiology as well as the Chemotherapy Induced Neutropenia market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Chemotherapy Induced Neutropenia market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Chemotherapy Induced Neutropenia…
Neutropenia Treatment Market to see Huge Growth by 2026 | Mylan, BeyondSpring, M …
Stay up-to-date and exploit latest trends of Neutropenia Treatment Market with latest edition released by AMA.
Neutropenia Treatment Market Comprehensive Study is an expert and top to bottom investigation on the momentum condition of the worldwide Neutropenia Treatment industry with an attention on the Global market. The report gives key insights available status of the Neutropenia Treatment producers and is an important wellspring of direction and course for organizations and people…
Chemotherapy Induced Thrombocytopenia Drugs Market In-Depth Analysis Of Competit …
Complete study of the global Chemotherapy Induced Thrombocytopenia Drugs market is carried out by the analysts in this report, taking into consideration key factors like drivers, challenges, recent trends, opportunities, advancements, and competitive landscape. This report offers a clear understanding of the present as well as future scenario of the global Chemotherapy Induced Thrombocytopenia Drugs industry. Research techniques like PESTLE and Porter's Five Forces analysis have been deployed by the…
